Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person15
Emergency One (UK) Ltd
Company · SC319443
COFORGE U.K. LIMITED
Company · 02648481
WILKER U.K. LIMITED
Company · 02849024
Technology One UK Limited
Company · 05234413
ENERGY AUDITING AGENCY LIMITED
Company · 01916768
Principal One Limited
Company · 11088176
OneAdvanced Limited
Company · 03214465
Craemer UK Limited
Company · 02574815
Vodafone UK Limited
Company · 01471587
EPI-USE Limited
Company · 03707885
OCF Limited
Company · 04132533
K.G.L. (ESTATES) LIMITED
Company · 01377507
Onclusive UK Limited
Company · 08984741
ELNET UK LIMITED
Company · 13763473
Kier Limited
Company · 01611136
Primary record5
EMERGENCY ONE (U.K.) LIMITED: ownership and control
EMERGENCY ONE (U.K.) LIMITED (company SC319443), incorporated 2007-03-23, status active. Current officers: BELL, Alistair (director); BELL, John Andrew (director); BELL, Steven (director); DAWSON, Lee (director); FERGUSO
EMERGENCY ONE (U.K.) LIMITED: ownership and control
EMERGENCY ONE (U.K.) LIMITED (company SC319443), incorporated 2007-03-23, status active. Current officers: BELL, Alistair (director); BELL, John Andrew (director); BELL, Steven (director); DAWSON, Lee (director); FERGUSO
EMERGENCY ONE (U.K.) LIMITED: ownership and control
EMERGENCY ONE (U.K.) LIMITED (company SC319443), incorporated 2007-03-23, status active. Current officers: BELL, Alistair (director); BELL, John Andrew (director); BELL, Steven (director); DAWSON, Lee (director); FERGUSO
EMERGENCY ONE (U.K.) LIMITED: ownership and control
EMERGENCY ONE (U.K.) LIMITED (company SC319443), incorporated 2007-03-23, status active. Current officers: BELL, Alistair (director); BELL, John Andrew (director); BELL, Steven (director); DAWSON, Lee (director); FERGUSO
Entrada Therapeutics, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 14, 2026, the Company issued a press release titled Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (D